pace your MRCP-PACES
Ir al canal en Telegram
2 526
Suscriptores
+324 horas
-47 días
-1030 días
Archivo de publicaciones
2 526
*🩺 Symptom Snapshot 6 – Orthopnoea*
(by pace your MRCP – Dr Tanzeel Bukhari)
*1️⃣ Left Ventricular Failure*
Breathlessness when lying flat
Improves on sitting upright or using multiple pillows
Due to pulmonary congestion
*2️⃣ Obesity / Obstructive Sleep Apnoea*
Difficulty breathing when supine
Loud snoring, daytime somnolence
Often co-exists with heart failure
*3️⃣ Diaphragmatic Weakness / Ascites*
Worse on lying flat due to reduced lung expansion
Seen in neuromuscular disease or tense ascites
2 526
*🩺 Symptom Snapshot 6 – Orthopnoea*
(by pace your MRCP – Dr Tanzeel Bukhari)
*1️⃣ Left Ventricular Failure*
Breathlessness when lying flat
Improves on sitting upright or using multiple pillows
Due to pulmonary congestion
*2️⃣ Obesity / Obstructive Sleep Apnoea*
Difficulty breathing when supine
Loud snoring, daytime somnolence
Often co-exists with heart failure
*3️⃣ Diaphragmatic Weakness / Ascites*
Worse on lying flat due to reduced lung expansion
Seen in neuromuscular disease or tense ascites
2 526
*🩺 Management Essentials 7*
(by pace your MRCP – Dr Tanzeel Bukhari)
*Ventricular Tachycardia (Stable vs Unstable)*
• Assume VT until proven otherwise in any wide-complex tachycardia in adults
• Unstable VT (shock, hypotension, ischaemic chest pain, acute heart failure, syncope) → immediate synchronised cardioversion
• Pulseless VT → treat as cardiac arrest: CPR + defibrillation + ALS
• Stable VT:
o Continuous monitoring, IV access, check electrolytes (K/Mg), treat reversible causes
o IV amiodarone is commonly first-line (or lidocaine per local protocol)
• Correct precipitants:
o Hypokalaemia / hypomagnesaemia, ischaemia, drug toxicity
• Early cardiology/ICU input; consider ICD assessment in structural heart disease
Pitfalls: mislabeling VT as SVT with aberrancy and giving inappropriate AV-nodal blockers
2 526
🩺 Management Essentials 6
(by pace your MRCP – Dr Tanzeel Bukhari)
Supraventricular Tachycardia (SVT)
• Initial approach: ABCDE, monitor, IV access, 12-lead ECG (but don’t delay treatment if unstable)
• Unstable (hypotension, chest pain, pulmonary oedema, shock, syncope) → synchronised DC cardioversion
• Stable, narrow-complex regular tachycardia:
o Vagal manoeuvres first (modified Valsalva preferred)
o If unsuccessful → IV adenosine in escalating doses (with full monitoring + resus readiness)
• If adenosine contraindicated/ineffective:
o IV beta-blocker or diltiazem/verapamil (avoid non-DHP CCBs in LV failure)
• Always look for and treat triggers: infection, pain, dehydration, stimulants, thyrotoxicosis
• Post-episode: consider electrophysiology referral if recurrent (ablation is definitive for AVNRT/AVRT)
Pitfalls: giving AV-nodal blockers in pre-excited AF (irregular wide-complex) → deterioration.
________________________________________
2 526
👉 IMPORTANT 815👈
The most typical laboratory abnormality in GCA is increased ESR and CRP.
Pace your MRCP-PACES.
2 526
👉 IMPORTANT 814👈
Visual loss in GCA may occur due to occlusion of posterior ciliary artery which can be a serious presentation.
pace your MRCP-PACES
2 526
👉 IMPORTANT 813👈
Many rheumatologists consider GCA and PMR as different manifestations of the same underlying disorder.
pace your MRCP-PACES
2 526
*Management Essentials No 5*
*Atrial Fibrillation – Long-Term Management*
• *Three pillars* : Rate control, Rhythm control, Anticoagulation
• CHA₂DS₂-VASc guides stroke prevention (not symptom severity)
• DOACs preferred unless contraindicated
• *Rhythm control considered in:*
o Young patients
o First episode
o AF causing heart failure
• *Lifestyle optimisation:* weight loss, BP control, sleep apnoea treatment
• *Rate control is acceptable long-term in many patients*
2 526
*Investigation Pearl 5 – D-dimer: Rule-Out Test, Not Rule-In*
*Key Principle* : Normal D‑dimer rules out VTE in low‑risk patients; raised D‑dimer does not confirm VTE.
Raised in infection, trauma, surgery, cancer, pregnancy and with age.
*Correct use* : assess clinical probability first; high probability → imaging (CTPA) without relying on D‑dimer.
*Exam tip* : Imaging confirms VTE, not D‑dimer.
¡Ya disponible! Investigación de Telegram 2025 — los principales insights del año 
